ReviewFrontiers in psychiatry2026
Revisiting the prevalence of bipolar disorder: implications of a broader spectrum model.
Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bipolar affective disorder has traditionally been defined by episodic mania and depression, largely restricted to Bipolar I and II categories. However, growing evidence suggests this framework underrepresents the broader longitudinal spectrum and may misclassify a subset of cases as borderline personality disorder (BPD) or other comorbidities. A narrative review was conducted, integrating historical and conceptual analyses of diagnostic frameworks (DSM-III to DSM-5), epidemiological studies over four decades, and the author's extensive clinical experience with longitudinal follow-up of complex affective cases. Literature addressing comorbidity, diagnostic delays, and symptom overlap was critically examined within a comparative and hypothesis-oriented framework. Findings indicate that bipolar spectrum disorders (BPSD) are substantially underdiagnosed, with prevalence plausibly exceeding traditional categorical estimates when cumulative longitudinal spectrum phenomena are considered. The suggested prevalence range of 15-20% represents a theoretical upper-bound hypothesis derived from clinical extrapolation and longitudinal observation, rather than a definitive epidemiological estimate. Conditions commonly diagnosed as BPD, ADHD, or anxiety may, in a subset of cases, represent longitudinal affective presentations overlapping with the bipolar spectrum. Evidence supports a spectrum model encompassing multiple subtypes, such as bipolar with panic attacks, ADHD comorbidity, antidepressant-induced mania, and ultra-rapid cycling. The continued use of BPD as a diagnostic category is questioned due to poor construct validity and overlap with bipolarity. Reconceptualizing bipolar disorder as a spectrum within a cautiously framed longitudinal model is essential to improve diagnostic accuracy, guide treatment, and optimize long-term outcomes, while remaining subject to prospective empirical validation. This manuscript is explicitly framed as a narrative, hypothesis-generating review rather than a systematic review or meta-analysis; accordingly, prevalence estimates discussed herein should be regarded as exploratory and conceptual rather than definitive epidemiological claims.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.